Literature DB >> 358295

The effect of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients.

M O Pulkkinen, A I Csapo.   

Abstract

In 12 dysmenorrheic patients we examined the therapeutic action of the Prostaglandin-synthesis inhibitor: Ibuprofen, a non-steroidal analgesic agent. Ibuprofen highly significantly reduced the resting pressure (P less than 0.001), active pressure (P less than 0.001) and frequency (P less than 0.05) of cyclic activity of the uterus, as well as menstrual pain (P less than 0.001). Since these effects occurred after a single oral dose of 800 mg Ibuprofen, without side effects or complications, extensive field trials are recommended with this and other PG-synthesis inhibitors, to assess their therapeutic benefits.

Entities:  

Keywords:  Analgesia--administraction and dosage; Analgesia--therapeutic use; Biology; Diseases; Dysmenorrhea--etiology; Endocrine System; Menstruation Disorders; Physiology; Pilot Projects; Prostaglandins; Research Methodology; Studies; Treatment

Mesh:

Substances:

Year:  1978        PMID: 358295     DOI: 10.1016/0090-6980(78)90048-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  10 in total

1.  Prostaglandin inhibitors: rational therapy for dysmenorrhea.

Authors:  J Sorbie
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

2.  Genetic and environmental factors in primary dysmenorrhea and its relationship to anxiety, depression, and neuroticism.

Authors:  J L Silberg; N G Martin; A C Heath
Journal:  Behav Genet       Date:  1987-07       Impact factor: 2.805

Review 3.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

Review 4.  Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

Authors:  S S Shapiro
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

5.  Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea.

Authors:  I Milsom; B Andersch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Comparison of postpartum pain treatments using a sequential trial design: II. Naproxen versus paracetamol.

Authors:  E Skovlund; G Fyllingen; H Landre; B I Nesheim
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 7.  Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

Authors:  Jane Marjoribanks; Reuben Olugbenga Ayeleke; Cindy Farquhar; Michelle Proctor
Journal:  Cochrane Database Syst Rev       Date:  2015-07-30

8.  Contribution to the pathogenesis of dysmenorrhea.

Authors:  H P Zahradnik; M Breckwoldt
Journal:  Arch Gynecol       Date:  1984

Review 9.  Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.

Authors:  A E Farah; F Rosenberg
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: A network meta-analysis.

Authors:  Xuan Feng; Xiaoyun Wang
Journal:  Mol Pain       Date:  2018-03-27       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.